Outcome and prognostic factors on 57 cases of infective endocarditis in a single centre

N Z Med J. 2009 Oct 9;122(1304):54-62.

Abstract

Aim: We aim to evaluate the clinical characteristics and outcome of infective endocarditis in our hospital, and the prognostic significance of recurrent endocarditis.

Methods: A single centre retrospective review of all cases of infective endocarditis (IE) was undertaken for a 5-year period from June 2002.

Results: There were 57 episodes of IE in 47 patients. Seventy percent were definite IE using the modified Duke Criteria (2000). The most commonly isolated organisms were Streptococci (37%) and Staphylococcus aureus (35%). Forty-nine percent of patients remained event-free from death, recurrence, or operation at the end of follow-up period. Five cases (8.5%) had early recurrence of endocarditis within 60 days. Eleven patients (23%) died during follow-up (mean 14 months). There was no significant increase in mortality of patients with history of recurrent endocarditis (38% vs 28%; p=0.39). Staphylococcus aureus was associated with increased mortality or need for valve surgery (OR 4.5; 95%CI 1.38-14.8), risk of neurological events (OR 8.9; 1.5-52), renal failure (OR 7.2; 1.7-30) and thrombocytopenia (OR 5.6; 1.4-22).

Conclusions: The mortality of IE remains high. Less than half of this cohort remained event-free. The micro-organism involved is more predictive of mortality or need for surgery than recurrent endocarditis.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Anti-Bacterial Agents / therapeutic use
  • Aortic Valve / surgery
  • Bioprosthesis / microbiology
  • Cohort Studies
  • Combined Modality Therapy
  • Disease-Free Survival
  • Echocardiography
  • Endocarditis, Bacterial / diagnosis*
  • Endocarditis, Bacterial / mortality
  • Endocarditis, Bacterial / surgery
  • Female
  • Follow-Up Studies
  • Heart Valve Prosthesis / microbiology
  • Humans
  • Male
  • Methicillin-Resistant Staphylococcus aureus
  • Middle Aged
  • Mitral Valve / surgery
  • New Zealand
  • Pacemaker, Artificial / microbiology
  • Recurrence
  • Retrospective Studies
  • Risk Factors
  • Staphylococcal Infections / diagnosis*
  • Staphylococcal Infections / mortality
  • Staphylococcal Infections / surgery
  • Streptococcal Infections / diagnosis*
  • Streptococcal Infections / mortality
  • Streptococcal Infections / surgery
  • Young Adult

Substances

  • Anti-Bacterial Agents